- Title
- Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products (NARCAN Price Cap Act)
- Sponsored by
- Delegates Vogel, Addison, Allen, Attar, Boafo, Conaway, Embry, Fair, Foley, Grossman, Kaufman, McCaskill, T. Morgan, Ruff, Spiegel, Wilkins, Wolek, Wu, and Young
- Status
- In the House - Withdrawn by Sponsor
- Analysis
- Fiscal and Policy Note
Synopsis
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid overdose without imposing a copayment or coinsurance requirement that exceeds $10 per package.
Committees
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
15-850.1 )
Last Updated: 4/15/2024 2:43 PM